Literature DB >> 16758167

[The importance of immunohistochemistry for the diagnosis of cholangiocarcinomas].

F Länger1, R von Wasielewski, H H Kreipe.   

Abstract

The correct diagnosis of intrahepatic cholangiocarcinoma (CC) is often confounded by the small size of the diagnostic specimen and the wide morphological range of carcinomas metastasising to the liver. Expression analysis of cytokeratins, glycoproteins, mucoproteins, adhesion molecules, receptors and transcription factors has been shown to be a valuable adjunct in the typing of carcinomas. For this study, the expression pattern of 30 well documented antibodies to CC and the most common metastatic adenocarcinomas of the liver were studied. CC show a rather distinct immunophenotype with co-expression of CK7, CK17, CD7 and a lack of CDX2. Although this pattern allows the separation of CC from most metastatic carcinomas, pancreatic carcinomas show a broad overlap with this expression pattern.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16758167     DOI: 10.1007/s00292-006-0836-z

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  24 in total

1.  A comparison of CD10 to pCEA, MOC-31, and hepatocyte for the distinction of malignant tumors in the liver.

Authors:  Carl Morrison; William Marsh; Wendy L Frankel
Journal:  Mod Pathol       Date:  2002-12       Impact factor: 7.842

2.  Immunohistochemistry can help distinguish metastatic pancreatic adenocarcinomas from bile duct adenomas and hamartomas of the liver.

Authors:  Jason L Hornick; Gregory Y Lauwers; Robert D Odze
Journal:  Am J Surg Pathol       Date:  2005-03       Impact factor: 6.394

3.  Immunohistochemical expression of cytokeratins in intrahepatic cholangiocarcinoma and metastatic adenocarcinoma of the liver.

Authors:  A Sasaki; K Kawano; M Aramaki; K Nakashima; T Yoshida; S Kitano
Journal:  J Surg Oncol       Date:  1999-02       Impact factor: 3.454

4.  Mutations of p53 tumor suppressor gene, apoptosis, and proliferation in intrahepatic cholangiocellular carcinoma of the liver.

Authors:  A Tannapfel; L Weinans; F Geissler; A Schütz; A Katalinic; F Köckerling; J Hauss; C Wittekind
Journal:  Dig Dis Sci       Date:  2000-02       Impact factor: 3.199

5.  Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis.

Authors:  A Rullier; B Le Bail; R Fawaz; J F Blanc; J Saric; P Bioulac-Sage
Journal:  Am J Surg Pathol       Date:  2000-06       Impact factor: 6.394

6.  Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer.

Authors:  Emad A Rakha; Richard W G Boyce; Dalia Abd El-Rehim; Thomas Kurien; Andrew R Green; Emma C Paish; John F R Robertson; Ian O Ellis
Journal:  Mod Pathol       Date:  2005-10       Impact factor: 7.842

7.  Hepatocyte paraffin 1 expression in human normal and neoplastic tissues: tissue microarray analysis on 3,940 tissue samples.

Authors:  Alessandro Lugli; Luigi Tornillo; Martina Mirlacher; Marcel Bundi; Guido Sauter; Luigi Maria Terracciano
Journal:  Am J Clin Pathol       Date:  2004-11       Impact factor: 2.493

8.  Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites: an immunohistochemical study.

Authors:  Sean K Lau; Lawrence M Weiss; Peiguo G Chu
Journal:  Am J Clin Pathol       Date:  2004-07       Impact factor: 2.493

9.  Expression of cytokeratins 7 and 20 in carcinomas of the gastrointestinal tract.

Authors:  A I Kende; N J Carr; L H Sobin
Journal:  Histopathology       Date:  2003-02       Impact factor: 5.087

10.  Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis.

Authors:  Akira Ishikawa; Motoko Sasaki; Shusaku Ohira; Tetsuo Ohta; Koji Oda; Yuji Nimura; Miin-Fu Chen; Yi-Yin Jan; Ta-Sen Yeh; Yasuni Nakanuma
Journal:  Lab Invest       Date:  2004-05       Impact factor: 5.662

View more
  3 in total

Review 1.  [Pitfalls in the classification of liver tumors].

Authors:  C Wittekind
Journal:  Pathologe       Date:  2006-07       Impact factor: 1.011

2.  [Cancer of unknown primary. Epidemiology and pathogenesis].

Authors:  H Löffler; K Neben; A Krämer
Journal:  Radiologe       Date:  2014-02       Impact factor: 0.635

3.  Identification of novel biomarker candidates for the immunohistochemical diagnosis of cholangiocellular carcinoma.

Authors:  Juliet Padden; Dominik A Megger; Thilo Bracht; Henning Reis; Maike Ahrens; Michael Kohl; Martin Eisenacher; Jörg F Schlaak; Ali E Canbay; Frank Weber; Andreas-Claudius Hoffmann; Katja Kuhlmann; Helmut E Meyer; Hideo A Baba; Barbara Sitek
Journal:  Mol Cell Proteomics       Date:  2014-07-17       Impact factor: 5.911

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.